They have no intention of doing so. They are going for 2nd line since both Tasigna and Sprycel will become first line. 2nd line will make them enough money to have a head to head trial in the future. Berger should go solo IMO. I still think he messed up not raising some cash when the stock price is at 4.
Market Data 
Markets 
AI
